Treatment for Endogenous Cushing's Syndrome
Completed · Phase 3
Conditions studied: Endogenous Cushing's Syndrome
In brief
The primary objectives of this study are to evaluate the clinical responder rate, defined as the proportion of subjects with normal UFC after 6 months of treatment with COR-003 in the Maintenance Phase without dose increase, and to evaluate the range of effective doses in subjects with various levels of hypercortisolism.
Key facts
- Study ID
- NCT01838551
- Run by
- Cortendo AB
- People needed
- 94
- Starts
- 2014-08-01
- Expected to finish
- 2018-11-01
- Last updated by the study team
- 2021-04-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA School of Medicine — Los Angeles, California, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- University of Michigan Medical Center — Ann Arbor, Michigan, United States
- University of New Mexico HSC — Albuquerque, New Mexico, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- Oregon Health & Science University — Portland, Oregon, United States
- Allegheny Neuroendocrinology Center — Pittsburgh, Pennsylvania, United States
- University Hospitals Leuven Department of Endocrinology — Leuven, Belgium
- University Specialized Hospital for Active Treatment in Endocrinology (USHATE) — Sofia, Bulgaria
- St. Pauls Hospital/Vancouver General Hospital — Vancouver, British Columbia, Canada
- Vseobecna fakultni nemocnice v Praze - III. Interni klinika VFN a 1. LF UK — Prague, Czechia
- Aarhus University Hospital — Aarhus, Denmark
- Rigshospitalet,Copenhagen University Hospital — Copenhagen, Denmark
- Hôpital de la CONCEPTION, Service d'Endocrinologie, Diabète et Maladies Métaboliques — Marseille, France
- Med Clinic I - University of Lueback — Lübeck, Germany
- Bnail Zion Medical Center Institute of Endocrinology & Metabolism — Haifa, Israel
- Institute of Endocrinology & Metabolism, Rabin Medical Center — Petah Tikva, Israel
- Sourasky Medical Center, Endocrinology & Metabolism — Tel Aviv, Israel
- Azienda Ospedaliera-Universitaria Ancona — Ancona, Italy
- UOC di Endocrinologia, Dipartimento di Medicina Clinica e Sperimentale — Messina, Italy
- Istituto Auxologico Italiano — Milan, Italy
- University of Naples Federico II — Naples, Italy
- SCDU Medicina Interna I Università di Torino Dipartimento di Scienze Cliniche e Biologiche — Orbassano, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.